Male | 54.2 |
Age years | 32.6±8.6 |
Height cm | 169.0±10.4 |
BMI kg·m−2 | 20.3±2.7 |
FEV1 L | 1.30±0.41 |
FEV1 % pred | 34.7±7.4 |
FVC L | 2.65±0.81 |
FVC % pred | 57.8±10.0 |
FEF25–75% L | 0.51±0.19 |
FEF25–75% % pred | 13.3±4.2 |
Diagnosis of CF-related diabetes mellitus | 33.3 |
Diagnosis of CF-related liver disease | 33.3 |
Use of supplementary oxygen therapy | 0.0 |
Azithromycin | 87.5 |
Recombinant human DNase | 58.3 |
Hypertonic saline | 58.3 |
Inhaled antibiotics | 41.4 |
Oral antibiotics | 33.3 |
Inhaled corticosteroids | 87.5 |
Oral corticosteroids | 4.2 |
Long-acting β2-agonists | 91.7 |
Long-acting muscarinic antagonists | 4.2 |
Data are presented as % or mean±sd. BMI: body mass index; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; FEF25–75%: forced expiratory flow at 25–75% of FVC.